Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 17.86% Profit, Confirming QuantWave's Accuracy

May 03, 2023
ELI LILLY AND COMPANY has recently achieved the forecasted price target as predicted by QuantWave, resulting in a profit of 17.86% for investors who followed the recommendation. The forecast signal was issued on December 29, 2022, with a price of 359.72 $. The direction indicated was long, and on May 3, 2023, the target was reached with a price of 423.98 $.

This successful forecast is a testament to QuantWave's advanced analytics and forecasting capabilities. Market analysis indicated several factors that contributed to ELI LILLY AND COMPANY's stock movement, including positive news on the company's drug development pipeline, strong financial performance, and overall market sentiment towards the healthcare sector.

QuantWave's accurate prediction for ELI LILLY AND COMPANY showcases the platform's ability to provide valuable insights for investors seeking opportunities for profitable trades. With a wide range of stocks covered, users can access forecasts for various assets, offering the potential for significant returns on investment.

For investors looking to enhance their understanding of QuantWave's forecasting system and investment strategies, QuantSchool provides comprehensive educational resources. By exploring QuantSchool's professional framework, investors can learn key principles for generating consistent income through the QuantWave platform, empowering them to make informed investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

UNHJuly 30, 2024UNITEDHEALTH GROUP INCORPORATED Hits 7.86% Profit Target as Forecasted by QuantWave  ~2 min.

UNITEDHEALTH GROUP INCORPORATED (NYSE: UNH) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 7.86% for investors....

CINovember 30, 2022THE CIGNA GROUP Stock Hits QuantWave's Price Target Forecast, Yielding 28.75% Profit  ~1 min.

QuantWave's forecast for THE CIGNA GROUP stock, issued on May 18, 2022, with a long direction signal at a price of 243.59 $, has successfully reached its target on November 30, 2022, at a price of 313.62 $....

SYKNovember 12, 2024STRYKER CORPORATION Hits Price Target Forecast with 12.26% Profit Margin  ~1 min.

On June 11, 2024, QuantWave issued a long signal for STRYKER CORPORATION when the stock was priced at 342.49 $. After careful analysis and prediction, the target price of 384....

ABBVJanuary 23, 2024ABBVIE INC. Hits Price Target Forecast with 11.17% Profit on QuantWave Platform  ~1 min.

ABBVIE INC. (NYSE: ABBV) recently achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profitable long position with an 11.17% gain....

UNHApril 21, 2025UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast with 11.12% Profit  ~1 min.

UNITEDHEALTH GROUP INCORPORATED, a leading healthcare company, has successfully achieved the price target forecast set by QuantWave....